SCHEMBL7765629

SCHEMBL7765629

O=C(NC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
HTT P42858 1/20 0.50
SYK P43405 1/20 0.46
SLC1A3 P43003 1/20 0.45
SLC1A1 P43005 1/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A3 Q01959 1/20 0.45
KMT2A Q03164 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
TGM2 P21980 1/20 0.45
CTRB1 P17538 2/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
CTSL P07711 1/20 0.44
CTSS P25774 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PLAU P00749 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14019069 0.88 LMNA (0.66) LMNASMN1; SMN2HTTSYKSLC1A3
SCHEMBL10576031 0.85 SYK (0.47) LMNASMN1; SMN2HTTSYKKMT2A
SCHEMBL11278594 0.85 LMNA (0.52) LMNASMN1; SMN2HTTSYKSLC1A3
SCHEMBL30400523 0.85 HTT (0.54) LMNASMN1; SMN2HTTTGM2KEAP1
SCHEMBL334682 0.84 LMNA (0.56) LMNASMN1; SMN2HTTSYKSLC1A3
SCHEMBL1568538 0.84 LMNA (0.56) LMNASMN1; SMN2HTTSYKSLC1A3
SCHEMBL1569295 0.84 LMNA (0.56) LMNASMN1; SMN2HTTSYKSLC1A3
SCHEMBL31207736 0.82 LMNA (0.58) LMNASMN1; SMN2HTTSYKSLC1A3
SCHEMBL19000309 0.82 CTRB1 (0.53) LMNASMN1; SMN2CTRB1CTSLCTSS
SCHEMBL5019087 0.82 LMNA (0.61) LMNASMN1; SMN2HTTSYKSLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0636363-B1 Drug delivery system TERUMO CORP (JP) 2001-05-23 EP disclosed
EP-0636363-A2 Drug delivery system TERUMO KABUSHIKI KAISHA (JP) 1995-02-01 EP disclosed
EP-0012278-B1 PREPARATION OF N-SUBSTITUTED DERIVATIVES OF 1-DEOXY-NOJIRIMYCINE BAYER AG (DE) 1982-05-19 EP disclosed
US-4266025-A Production of N-substituted derivatives of 1-desoxy-nojirimycin BAYER AKTIENGESELLSCHAFT (DE) 1981-05-05 US disclosed
EP-0012278-A2 Preparation of N-substituted derivatives of 1-deoxy-nojirimycine BAYER AG (DE) 1980-06-25 EP disclosed